dc.relation.references | 1. Diretrizes Brasileiras de Rinossinusites. Rev Bras Otorrinolaringol. 2008;74:6-59.
2. Lu VJ, Fokk WJ, He PW. European Position Paper on Rhinosinusitis and Mensagem do Presidente. 2020;
3. Anselmo-Lima WTerezinha. Tratado de Otorrinolaringologia. 3 ed. Rio de Janeiro: Elsevier; 2018.
4. Bryson JM, Tasca RA, Rowe-Jones JM. Local and systemic eosinophilia in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis with and without polyposis. Clin Otolaryngol Allied Sci. 2003;28(1):55–8.
5. Sreeparvathi A, Kalyanikuttyamma LK, Kumar M, Sreekumar N, Veerasigamani N. Significance of blood eosinophil count in patients with chronic rhinosinusitis with nasal polyposis. Journal of Clinical and Diagnostic Research. 2017;11(2):MC08-MC11.
6. Tajudeen BA, Ganti A, Kuhar HN, Mahdavinia M, Heilingoetter A, Gattuso P, et al. The presence of eosinophil aggregates correlates with increased postoperative prednisone requirement. Laryngoscope. 2019;129(4):794–9.
7. Kovalhuk LCS, Telles EQ, Lima MN, Rosario Filho NA. Nasal lavage cytology and mucosal histopathological alterations in patients with rhinitis. Braz J Otorhinolaryngol [Internet]. 2020;86(4):434–42. Available from: https://doi.org/10.1016/j.bjorlp.2020.04.002
8. Brasil N, Brasileiro C, Rinossinusites S. 1 introdução. 1999;6–59.
9. Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. Journal of Allergy and Clinical Immunology. 2016 May 1;137(5):1449-1456.e4.
10. Thomas J, Corsello C. Nasal polyps: epidemiology, pathogenesis and treatment. J Autism Dev Disord. 1999;29(3):265–7.
11. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. Journal of Allergy and Clinical Immunology: In Practice. 2016 Jul 1;4(4):565–72.
12. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999;28(4):717–22.
13. Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic Rhinosinusitis with Nasal Polyps and Asthma. Journal of Allergy and Clinical Immunology: In Practice. 2021 Mar 1;9(3):1133–41.
14. Hellings PW, Fokkens WJ, Orlandi R, Adriaensen GF, Alobid I, Baroody FM, et al. The EUFOREA pocket guide for chronic rhinosinusitis*. Vol. 61, Rhinology. International Rhinologic Society; 2023. p. 85–9.
15. Fokkens WJ, Viskens AS, Backer V, Conti D, de Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023;61(3):194–202.
16. Wu D, Bleier BS, Wei Y. Progression from nasal polyps to adult-onset asthma: a different process from atopic march? Rhinol Online. 2018 Mar 1;1(1):22–9.
17. Castillo JA PVRGJBMJ. Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity .
18. Pawankar R. Nasal polyposis: An update. Curr Opin Allergy Clin Immunol. 2003;3(1):1–6.
19. Hens G, Hellings PW. The nose: Gatekeeper and trigger of bronchial disease. Rhinology. 2006;44(3):179–87.
20. Bimestral P. Recomendações para o manejo da asma da Sociedade Brasileira de Pneumologia e Tisiologia – 2020. J Bras Pneumol v Jornal Brasileiro de Pneumologia Abril. 2012;38(1):1–46.
21. Fahy J V. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol [Internet]. 2015;15(1):57–65. Available from: http://dx.doi.org/10.1038/nri3786
22. Peters MC, Kerr S, Dunican EM, Woodruff PG, Fajt ML, Levy BD, et al. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 2019 Jan 1;143(1):104-113.e14.
23. Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic Rhinosinusitis with Nasal Polyps and Asthma. Journal of Allergy and Clinical Immunology: In Practice. 2021 Mar 1;9(3):1133–41.
24. J J Braun 1 , F Haas CC. Polyposis of the nasal sinuses. Epidemiology and clinical aspects of 350 cases. Treatment and results with a follow-up over 5 years on 93 cases. Ann Otolaryngol Chir Cervicofac . 1992;109(4):189-99.;
25. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. Journal of Allergy and Clinical Immunology. 2003;111(5):913–21.
26. Stevens WW, Schleimer RP. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis. Vol. 36, Immunology and Allergy Clinics of North America. W.B. Saunders; 2016. p. 669–80.
27. Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Vol. 77, Allergy: European Journal of Allergy and Clinical Immunology. John Wiley and Sons Inc; 2022. p. 812–26.
28. Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. Journal of Allergy and Clinical Immunology. 2016 May 1;137(5):1449-1456.e4.
29. Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. Journal of Allergy and Clinical Immunology. 2016 May 1;137(5):1449-1456.e4.
30. Zhai Z, Shao L, Lu Z, Yang Y, Wang J, Liu Z, et al. Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis. Vol. 14, Clinical and Translational Allergy. John Wiley and Sons Inc; 2024.
31. Green RH, Brightling CE, Woltmann G, Parker D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids [Internet]. Available from: www.thoraxjnl.com
32. Kato A. Immunopathology of chronic rhinosinusitis. Vol. 64, Allergology International. Japanese Society of Allergology; 2015. p. 121–30.
33. Kroegel C, Virchow JC, Luttmann W, Walker C, Warner JA. Pulmonary immune cells in health and disease: The eosinophil leucocyte (Part I). European Respiratory Journal. 1994;7(3):519–43.
34. Quirce S, Cosío BG, España A, Blanco R, Mullol J, Santander C, et al. Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach. Front Immunol. 2023;14.
35. Yao Y, Xie S, Yang C, Zhang J, Wu X, Sun H. Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis. Vol. 274, European Archives of Oto-Rhino-Laryngology. Springer Verlag; 2017. p. 3559–66.
36. Kim SJ, Lee KH, Kim SW, Cho JS, Park YK, Shin SY. Changes in histological features of nasal polyps in a Korean population over a 17-year period. In: Otolaryngology - Head and Neck Surgery (United States). 2013. p. 431–7.
37. Macchi A, Giorli A, Cantone E, Carlotta Pipolo G, Arnone F, Barbone U, et al. Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients. Frontiers in Allergy. 2023;4.
38. Lou H, Zhang N, Bachert C, Zhang L. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018;8(11):1218–25.
39. Pawankar R, Nonaka M. Infl ammatory Mechanisms and Remodeling in Chronic Rhinosinusitis and Nasal Polyps. Curr Allergy Asthma Rep. 2007;7:202–8.
40. Sreeparvathi A, Kalyanikuttyamma LK, Kumar M, Sreekumar N, Veerasigamani N. Significance of blood eosinophil count in patients with chronic rhinosinusitis with nasal polyposis. Journal of Clinical and Diagnostic Research. 2017 Feb 1;11(2):MC08-MC11.
41. Vlaminck S, Vauterin T, Hellings PW, Jorissen M, Acke F, Van Cauwenberge P, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: A 3-year prospective observational study. Am J Rhinol Allergy. 2014;28(3):260–4.
42. Garín L, Armengot M, Ramón Alba J, Carda C. Correlations Between Clinical and Histological Aspects in Nasal Polyposis. Acta Otorrinolaringologica (English Edition). 2008 Jan;59(7):315–20.
43. Aslan F, Altun E, Paksoy S, Turan G. Could Eosinophilia predict clinical severity in nasal polyps? Multidiscip Respir Med. 2017 Aug 21;12(1).
44. Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, et al. The skin prick test - European standards. Clin Transl Allergy. 2013 Feb 1;3(1):1–10.
45. Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organization Journal. 2020 Feb 1;13(2).
46. Haahtela T, Burbach GJ, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, et al. Clinical relevance is associated with allergen-specific wheal size in skin prick testing. Clinical and Experimental Allergy. 2014 Mar;44(3):407–16.
47. Bakhshaee M, Fereidouni M, Mohajer MN, Majidi MR, Azad FJ, Moghiman T. The prevalence of allergic fungal rhinosinusitis in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2013;270(12):3095–8.
48. Kosugi EM, Chen VG, Guerreiro Da Fonseca VM, Martins M, Cursino P, Arruda J, et al. Translation, cross-cultural adaptation and validation of SinoNasal Outcome Test (SNOT)-22 to Brazilian Portuguese [Internet]. Vol. 77, Brazilian Journal of otorhinolaryngology. 2011. Available from: http://www.bjorl.org.br/
49. Abdalla S, Alreefy H&, Hopkins C. Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit.
50. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: Developing guidance for clinical trials. Journal of Allergy and Clinical Immunology. 2006 Nov;118(5 SUPPL.).
51. Aslan F, Altun E, Paksoy S, Turan G. Could Eosinophilia predict clinical severity in nasal polyps? Multidiscip Respir Med. 2017;12(1):1–5.
52. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. American Review of Respiratory Disease. 1988;138(2):406–12.
53. Amorim MM, Fernandes PBL, Caetano LB, Dracoulakis S, Santoro IL, Fernandes ALG. Nasal lavage is better than blood count in predicting sputum eosinophilia. Clinical and Experimental Allergy. 2015;45(5):1006–8.
54. Cruz AA, Naclerio RM, Proud D, Togias A. Epithelial shedding is associated with nasal reactions to cold, dry air. Journal of Allergy and Clinical Immunology. 2006;117(6):1351–8.
55. Lorenzo G Di, Drago A, Pellitteri ME, Candore G, Colombo A, Gervasi F, et al. Measurement of Inflammatory Mediators of Mast Cells and Eosinophils in Native Nasal Lavage Fluid in Nasal Polyposis [Internet]. Vol. 125, Int Arch Allergy Immunol. 2001. Available from: www.karger.com/journals/iaa
56. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. Journal of Allergy and Clinical Immunology: In Practice. 2016 Jul 1;4(4):565–72.
57. Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Vol. 36, Current Medical Research and Opinion. Taylor and Francis Ltd.; 2020. p. 1897–911.
58. Macchi A, Giorli A, Cantone E, Carlotta Pipolo G, Arnone F, Barbone U, et al. Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients. Frontiers in Allergy. 2023;4.
59. Chen S, Zhou A, Emmanuel B, Garcia D, Rosta E. Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis. Vol. 36, Current Medical Research and Opinion. Taylor and Francis Ltd.; 2020. p. 1913–26.
60. Bai J, Huang JH, Price CPE, Schauer JM, Suh LA, Harmon R, et al. Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 2022 Aug 1;150(2):352-361.e7.
61. Eghtedari F, Reza Cheraghzadeh S, Amin Kashef M, Monabati A, Kashef S. Agreement Rate of Skin Prick Test with Tissue Eosinophil Count in Patients with Nasal Polyps. Vol. 6, IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY. All rights reserved. Iran J Allergy Asthma Immunol. 2007.
62. Kaboodkhani R, Bolkheir A, Esmaeilzadeh H, Faramarzi M, Ashraf M, Hosseinialhashemi M, et al. Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping. Iranian Journal of Pharmaceutical Research. 2021 Oct 1;20(4):21–8.
63. Ahmadiafshar A, Farjd HR, Moezzi F, Mousavinasab N. Nasal polyposis in patients with asthma and allergic rhinitis. Journal of Laryngology and Otology. 2012 Aug;126(8):780–3.
64. Loftus CA, Soler ZM, Koochakzadeh S, Desiato VM, Yoo F, Nguyen SA, et al. Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors. Int Forum Allergy Rhinol. 2020 Feb 1;10(2):199–207.
65. Lange B, Holst R, Thilsing T, Baelum J‡, Kjeldsen A. Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: A prospective questionnaire and clinical cross-sectional study. 2013.
66. Calus L, Van Bruaene N, Bosteels C, Dejonckheere S, Van Zele T, Holtappels G, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy. 2019 Jun 14;9(1).
67. Lou H, Meng Y, Piao Y, Wang C, Zhang L, Bachert C. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population. Am J Rhinol Allergy. 2015 Sep 1;29(5):350–6.
68. Tokunaga T, Sakashita M, Haruna T, Asaka D, Takeno S, Ikeda H, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC Study. Allergy: European Journal of Allergy and Clinical Immunology. 2015 Aug 1;70(8):995–1003.
69. Drake VE, Rafaels N, Kim J. Peripheral blood eosinophilia correlates with hyperplastic nasal polyp growth. Int Forum Allergy Rhinol. 2016 Sep 1;6(9):926–34.
| pt_BR |